Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system by Wensheng Liu, Wensheng Liu, Feifei Gao, Feifei Gao, Xue Song, Hao Chen, Hao Chen, Youjun She, Youjun She, Jiyong Liu, Jiyong Liu, Qiong Du, Qiong Du

Get full text

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter, Real-World Study by Han Shan, Mengmeng Wang, Shuohan Huang, Hongyue Liu, Jiyong Liu, Qiong Du

Get full text

Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis by Xuan Ye, Xuan Ye, Linlin Wang, Wensheng Liu, Wensheng Liu, Mengmeng Wang, Mengmeng Wang, Zihan Guo, Zihan Guo, Han Shan, Han Shan, Qing Zhai, Qing Zhai, Qiong Du, Qiong Du

Get full text

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis by Xuhui Tong, Rong Tang, Jin Xu, Wei Wang, Qiong Du, Si Shi, Xianjun Yu

Get full text

Derivation of soil Pb/Cd/As thresholds for safety of vegetable planting: A case study for pakchoi in Guangdong Province, China by Fu-rong LI, Dian WEN, Fu-hua WANG, Fang-fang SUN, Xu WANG, Ying-qiong DU, Xiang-xiang LIU, Kai WAN

Get full text